Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025)
Envoy Medical (COCH) reported Cash from Investing Activities of -$172000.0 for Q4 2025, down 132.21% on a YoY basis from $534000.0 in Q4 2024, and down 17100.0% sequentially from -$1000.0 in Q2 2025.
Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Envoy Medical (COCH) has 5 years of Cash from Investing Activities data on file, last reported at -$172000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities fell 132.21% year-over-year to -$172000.0; the trailing twelve-month figure through Dec 2025 stood at -$179000.0 (up 81.73% YoY), and the FY2025 full-year result was -$179000.0, up 81.73% from the prior year.
- Cash from Investing Activities slipped to -$172000.0 in Q4 2025, from -$1000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $534000.0 in Q4 2024 to a low of -$420.0 million in Q1 2021.
- A 5-year average of -$30.5 million and a median of -$60500.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 2642.86% in 2024, while the deepest fall reached 7081.82% in 2024.
- Tracing COCH's Cash from Investing Activities over 5 years: stood at -$5.0 million in 2021, then soared by 99.18% to -$41000.0 in 2022, then jumped by 48.78% to -$21000.0 in 2023, then surged by 2642.86% to $534000.0 in 2024, then plunged by 132.21% to -$172000.0 in 2025.
- Business Quant data shows COCH's Cash from Investing Activities at -$172000.0 in Q4 2025, -$1000.0 in Q2 2025, and -$6000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Envoy Medical | 47.34 Mn | 22.09 Mn | -274,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172,000.00 |
| Dec 31, 2025 | -172,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -11,000.00 |